Form 4: InspireMD Director Gary S. Roubin Reports Stock and Option Transactions
SEC Form 4
Director Gary S. Roubin reports acquisition and disposal of InspireMD, Inc. stock and options.
Summary
- On January 7, 2025, Gary S. Roubin, a director of InspireMD, Inc. (NSPR), reported transactions involving the company's stock and options.
- Roubin acquired 32,491 shares of common stock at $0, which are restricted and will vest on January 7, 2026, contingent upon continued service.
- Roubin also acquired options to purchase 14,836 shares of common stock at an exercise price of $2.71, which will vest on January 7, 2026, also contingent upon continued service.
- Following these transactions, Roubin directly owns 534,279 shares of common stock and 91,743 derivative securities.
- A power of attorney was executed by Craig Shore on behalf of Gary S. Roubin on January 10, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock and option transactions by a director. The acquisition of shares and options could be interpreted as a positive sign, but it's not definitively bullish.
Positives
- The acquisition of restricted stock and options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Risks
- The vesting of the restricted stock and options is contingent upon the Reporting Person's continued service, which introduces a dependency on their continued involvement with the company.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of stock and options in the future suggests an expectation of continued service and potentially positive performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership structure and management's stake in the company.
Stakeholder Impact
- The transactions could have a minor impact on shareholders by slightly increasing the director's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 01/07/2025 | Date of stock and option transactions. |
| 01/07/2026 | Vesting date for restricted stock and options. |
| 01/07/2035 | Expiration date for options to purchase common stock. |
| 01/10/2025 | Date of Power of Attorney execution. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.